{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:28:08Z","timestamp":1791142088911,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001288","name":"Parkinson's Disease Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001288","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.expneurol.2004.07.012","type":"journal-article","created":{"date-parts":[[2004,12,13]],"date-time":"2004-12-13T12:55:06Z","timestamp":1102942506000},"page":"86-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["A novel azulenyl nitrone antioxidant protects against MPTP and 3-nitropropionic acid neurotoxicities"],"prefix":"10.1016","volume":"191","author":[{"given":"Lichuan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel Y.","family":"Calingasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Ley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Flint","family":"Beal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2004.07.012_bib1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1570-0232(02)00273-8","article-title":"Rapid, fluorimetric-liquid chromatographic determination of malondialdehyde in biological samples","volume":"775","author":"Agarwal","year":"2002","journal-title":"J. Chromatogr., B, Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.expneurol.2004.07.012_bib2","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1046\/j.1471-4159.1997.69031326.x","article-title":"A generalized increase in protein carbonyl in the brain in Parkinson's but not incidental Lewy body disease","volume":"69","author":"Alam","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2004.07.012_bib3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1023\/A:1007680616056","article-title":"Neuroprotective effect of acute and chronic administration of copper (II) sulfate against MPP+ neurotoxicity in mice","volume":"26","author":"Alcaraz-Zubeldia","year":"2001","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.expneurol.2004.07.012_bib4","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S0891-5849(97)00338-9","article-title":"Azulenyl nitrones: colorimetric detection of oxyradical end products and neuroprotection in the gerbil transient forebrain ischemia\/reperfusion model","volume":"24","author":"Althaus","year":"1998","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.expneurol.2004.07.012_bib5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1006\/exnr.2000.7525","article-title":"Mice with a partial deficiency of manganese superoxide dismutase show increased vulnerability to the mitochondrial toxins malonate, 3-nitropropionic acid, and MPTP","volume":"167","author":"Andreassen","year":"2001","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2004.07.012_bib6","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/j.1471-4159.1990.tb03143.x","article-title":"Kynurenine pathway measurements in Huntington's disease striatum: evidence for reduced formation of kynurenic acid","volume":"55","author":"Beal","year":"1990","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2004.07.012_bib7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/0022-510X(92)90191-M","article-title":"Kynurenic acid concentrations are reduced in Huntington's disease cerebral cortex","volume":"108","author":"Beal","year":"1992","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2004.07.012_bib8","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1046\/j.1471-4159.1995.65020919.x","article-title":"3-Nitropropionic acid neurotoxicity is attenuated in copper\/zinc superoxide dismutase transgenic mice","volume":"65","author":"Beal","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2004.07.012_bib9","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1021\/ja952895z","article-title":"Highly sensitive colorimetric detection and facile isolation of diamagnetic free radical adducts of novel chromotropic nitrone spin trapping agents readily derived from guaiazulene","volume":"118","author":"Becker","year":"1996","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.expneurol.2004.07.012_bib10","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s000180050457","article-title":"Diagnostic and therapeutic applications of azulenyl nitrone spin traps","volume":"56","author":"Becker","year":"1999","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.expneurol.2004.07.012_bib11","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1021\/ja011507s","article-title":"Stilbazulenyl nitrone (STAZN): a nitronyl-substituted hydrocarbon with the potency of classical phenolic chain-breaking antioxidants","volume":"124","author":"Becker","year":"2002","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.expneurol.2004.07.012_bib12","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3171\/jns.2002.96.6.1077","article-title":"Stilbazulenyl nitrone, a novel azulenyl nitrone antioxidant: improved neurological deficit and reduced contusion size after traumatic brain injury in rats","volume":"96","author":"Belayev","year":"2002","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.expneurol.2004.07.012_bib13","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0022-510X(90)90225-C","article-title":"The MPTP model: versatile contributions to the treatment of idiopathic Parkinson's disease","volume":"97","author":"Bloem","year":"1990","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2004.07.012_bib14","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1046\/j.1471-4159.1998.71062642.x","article-title":"Increased vulnerability to 3-nitropropionic acid in an animal model of Huntington's disease","volume":"71","author":"Bogdanov","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2004.07.012_bib15","doi-asserted-by":"crossref","first-page":"7105","DOI":"10.1073\/pnas.92.15.7105","article-title":"Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates","volume":"92","author":"Brouillet","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2004.07.012_bib16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1750-3639.1999.tb00216.x","article-title":"Oxidative stress in Huntington's disease","volume":"9","author":"Browne","year":"1999","journal-title":"Brain Pathol."},{"key":"10.1016\/j.expneurol.2004.07.012_bib17","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0891-5849(92)90151-6","article-title":"Intracranial microdialysis of salicylic acid to detect hydroxyl radical generation through dopamine autooxidation in the caudate nucleus: effects of MPP+","volume":"13","author":"Chiueh","year":"1992","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.expneurol.2004.07.012_bib18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1749-6632.1994.tb21786.x","article-title":"In vivo generation of hydroxyl radicals and MPTP-induced dopaminergic toxicity in the basal ganglia","volume":"738","author":"Chiueh","year":"1994","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2004.07.012_bib39","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/mds.870090115","article-title":"Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study","volume":"9","author":"Dexter","year":"1994","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2004.07.012_bib19","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/BF01291877","article-title":"MPTP-induced deficits in motor activity: neuroprotective effects of the spintrapping agent, alpha-phenyl-tert-butyl-nitrone (PBN)","volume":"104","author":"Fredriksson","year":"1997","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.expneurol.2004.07.012_bib20","first-page":"985","article-title":"Oxidative damage linked to neurodegeneration by selective a-Synuclein nitration in synucleinopathy lesions","volume":"290","author":"Giasson","year":"2000","journal-title":"Sci. Mag."},{"key":"10.1016\/j.expneurol.2004.07.012_bib21","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/ana.10659","article-title":"Stilbazulenyl nitrone, a novel antioxidant, is highly neuroprotective in focal ischemia","volume":"54","author":"Ginsberg","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2004.07.012_bib22","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/00005072-199804000-00006","article-title":"Protein nitration in Parkinson's disease","volume":"57","author":"Good","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2004.07.012_bib23","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00004647-200001000-00016","article-title":"Excitotoxicity is required for induction of oxidative stress and apoptosis in mouse striatum by the mitochondrial toxin, 3-nitropropionic acid","volume":"20","author":"Kim","year":"2000","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.expneurol.2004.07.012_bib24","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1006\/exnr.1998.6824","article-title":"Azulenyl nitrone spin traps protect against MPTP neurotoxicity","volume":"152","author":"Klivenyi","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2004.07.012_bib25","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1006\/nbdi.1998.0191","article-title":"Manganese superoxide dismutase overexpression attenuates MPTP toxicity","volume":"5","author":"Klivenyi","year":"1998","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2004.07.012_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1523\/JNEUROSCI.20-01-00001.2000","article-title":"Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic acid, and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine","volume":"20","author":"Klivenyi","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2004.07.012_bib27","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1006\/abbi.1993.1272","article-title":"In vivo spin trapping of xenobiotic free radical metabolites","volume":"303","author":"Knecht","year":"1993","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.expneurol.2004.07.012_bib28","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0006-8993(00)01948-X","article-title":"3-nitropropionic acid induced in vivo protein oxidation in striatal and cortical synaptosomes: insights into Huntington's disease","volume":"858","author":"La Fontaine","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2004.07.012_bib29","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1006\/exnr.1999.7045","article-title":"Novel free radical spin traps protect against malonate and MPTP neurotoxicity","volume":"157","author":"Matthews","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2004.07.012_bib30","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1523\/JNEUROSCI.12-05-01658.1992","article-title":"Transgenic mice with increased Cu\/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity","volume":"12","author":"Przedborski","year":"1992","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2004.07.012_bib31","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1073\/pnas.78.2.1001","article-title":"Dimethyl sulfoxide prevents DNA nicking mediated by ionizing radiation or iron\/hydrogen peroxide-generated hydroxyl radical","volume":"78","author":"Repine","year":"1981","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2004.07.012_bib32","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/00207450108986505","article-title":"Taurine increases rat survival and reduces striatal damage caused by 3-nitropropionic acid","volume":"108","author":"Rivas-Arancibia","year":"2001","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.expneurol.2004.07.012_bib33","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1600-0773.1993.tb01345.x","article-title":"Increased striatal lipid peroxidation after intracerebroventricular MPP+ administration to mice","volume":"72","author":"Rojas","year":"1993","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.expneurol.2004.07.012_bib40","first-page":"197","article-title":"A marker of oxyradical-mediated DNA damage (8-hydroxy-2'deoyguanosine) is increased in nigro-striatum of Parkinson's disease brain","volume":"3","author":"Sanchez-Ramos","year":"1994","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.expneurol.2004.07.012_bib34","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0014-4886(95)90033-0","article-title":"Coenzyme Q10 and nicotinamide and a free radical spin trap protect against MPTP neurotoxicity","volume":"132","author":"Schulz","year":"1995","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2004.07.012_bib35","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0197-0186(95)00122-0","article-title":"Involvement of oxidative stress in 3-nitropropionic acid neurotoxicity","volume":"29","author":"Schulz","year":"1996","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.expneurol.2004.07.012_bib36","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0304-3940(97)00915-4","article-title":"Dimethylsulfoxide (DMSO) treatment reduces infarction volume after permanent focal cerebral ischemia in rats","volume":"239","author":"Shimizu","year":"1997","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2004.07.012_bib41","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0304-3940(92)90355-B","article-title":"Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease","volume":"142","author":"Sofic","year":"1992","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2004.07.012_bib37","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0006-8993(99)02202-7","article-title":"In vivo hydroxyl radical generation in the striatum following systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice","volume":"852","author":"Thomas","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2004.07.012_bib38","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/j.1471-4159.1993.tb13610.x","article-title":"Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds","volume":"61","author":"Tipton","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2004.07.012_bib42","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0002-9440(10)65396-5","article-title":"Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons","volume":"154","author":"Zhang","year":"1999","journal-title":"Am. J. Pathol."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488604002766?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488604002766?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T21:42:26Z","timestamp":1772228546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488604002766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0014488604002766"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2004.07.012","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel azulenyl nitrone antioxidant protects against MPTP and 3-nitropropionic acid neurotoxicities","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2004.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}